跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection - TGA Drug Approval Details
Approvals
/
TGA
/
RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection
Approved
STANDARD
RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection
Piramal Critical Care Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
e29cbe22dd554dcd
Company
Piramal Critical Care Pty Ltd
Type
Standard
Approval Details
Approval Id
e29cbe22dd554dcd
Product Name
RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection
Artg Id
50508
Artg Name
RAPIFEN alfentanil 5mg/10mL (as hydrochloride) injection, ampoule
Sponsor
Piramal Critical Care Pty Ltd
Company Detail Path
/organization/piramal-critical-care-pty-ltd
Artg Date
1994-10-14
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01400-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-PI-01399-1
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
e29cbe22dd554dcd
Type
Standard
Back to TGA Approvals